Neil Gregory Almstead - Net Worth and Insider Trading
Neil Gregory Almstead Net Worth
The estimated net worth of Neil Gregory Almstead is at least $3 Million dollars as of 2024-11-13. Neil Gregory Almstead is the CHIEF TECHNICAL OPS OFFICER of PTC Therapeutics Inc and owns about 64,908 shares of PTC Therapeutics Inc (PTCT) stock worth over $3 Million. Details can be seen in Neil Gregory Almstead's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Neil Gregory Almstead has not made any transactions after 2024-01-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Neil Gregory Almstead
Neil Gregory Almstead Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Neil Gregory Almstead owns 1 companies in total, including PTC Therapeutics Inc (PTCT) .
Click here to see the complete history of Neil Gregory Almstead’s form 4 insider trades.
Insider Ownership Summary of Neil Gregory Almstead
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PTCT | PTC Therapeutics Inc | 2024-01-30 | EVP Research Pharma Ops & Tech |
Neil Gregory Almstead Latest Holdings Summary
Neil Gregory Almstead currently owns a total of 1 stock. Neil Gregory Almstead owns 64,908 shares of PTC Therapeutics Inc (PTCT) as of January 30, 2024, with a value of $3 Million.
Latest Holdings of Neil Gregory Almstead
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PTCT | PTC Therapeutics Inc | 2024-01-30 | 64,908 | 44.62 | 2,896,195 |
Holding Weightings of Neil Gregory Almstead
Neil Gregory Almstead Form 4 Trading Tracker
According to the SEC Form 4 filings, Neil Gregory Almstead has made a total of 19 transactions in PTC Therapeutics Inc (PTCT) over the past 5 years, including 0 buys and 19 sells. The most-recent trade in PTC Therapeutics Inc is the sale of 646 shares on January 30, 2024, which brought Neil Gregory Almstead around $17,604.
Insider Trading History of Neil Gregory Almstead
- 1
Neil Gregory Almstead Trading Performance
Neil Gregory Almstead Ownership Network
Ownership Network List of Neil Gregory Almstead
Ownership Network Relation of Neil Gregory Almstead
Neil Gregory Almstead Owned Company Details
What does PTC Therapeutics Inc do?
Who are the key executives at PTC Therapeutics Inc?
Neil Gregory Almstead is the EVP Research Pharma Ops & Tech of PTC Therapeutics Inc. Other key executives at PTC Therapeutics Inc include CHIEF FINANCIAL OFFICER Pierre Gravier , Chief Medical Officer Lee Scott Golden , and Chief Development Officer Matthew B. Klein .
PTC Therapeutics Inc (PTCT) Insider Trades Summary
Over the past 18 months, Neil Gregory Almstead made 2 insider transaction in PTC Therapeutics Inc (PTCT) with a net sale of 3,556. Other recent insider transactions involving PTC Therapeutics Inc (PTCT) include a net sale of 22,039 shares made by Eric Pauwels , a net sale of 22,455 shares made by Matthew B. Klein , and a net sale of 2,701 shares made by Lee Scott Golden .
In summary, during the past 3 months, insiders sold 0 shares of PTC Therapeutics Inc (PTCT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 114,302 shares of PTC Therapeutics Inc (PTCT) were sold and 7,700 shares were bought by its insiders, resulting in a net sale of 106,602 shares.
PTC Therapeutics Inc (PTCT)'s detailed insider trading history can be found in Insider Trading Tracker table.
PTC Therapeutics Inc Insider Transactions
Neil Gregory Almstead Mailing Address
Above is the net worth, insider trading, and ownership report for Neil Gregory Almstead. You might contact Neil Gregory Almstead via mailing address: C/o Ptc Therapeutics, Inc., 100 Corporate Court, South Plainfield Nj 07080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
